21 CFR 250, Subpart B - New Drug or Prescription Status of Specific Drugs
- § 250.100 — Amyl nitrite inhalant as a prescription drug for human use.
- § 250.101 — Amphetamine and methamphetamine inhalers regarded as prescription drugs.
- § 250.102 — Drug preparations intended for human use containing certain “coronary vasodilators”.
- §§ 250.103-250.104 — [Reserved]
- § 250.105 — Gelsemium-containing preparations regarded as prescription drugs.
- §§ 250.106-250.107 — [Reserved]
- § 250.108 — Potassium permanganate preparations as prescription drugs.
Title 21 published on 2012-04-01
no entries appear in the Federal Register after this date.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
